Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.

Literature DB >> 4872909

Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.

E H Uhlenhuth, K Rickels, S Fisher, L C Park, R S Lipman, J Mock.

Abstract

Mesh：

Substances：
Placebos
Meprobamate

Year: 1966 PMID： 4872909 DOI： 10.1007/BF00406450

Source DB: PubMed Journal: Psychopharmacologia

× No keyword cloud information.

14 in total

1. PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.

Authors: M S GUTTMACHER
Journal: Arch Gen Psychiatry Date: 1964-03

2. AN ANALYSIS OF MOOD IN NEUROTICS.

Authors: D M MCNAIR; M LORR
Journal: J Abnorm Psychol Date: 1964-12

3. Therapist "type" and patient response to psychotherapy.

Authors: D M MCNAIR; D M CALLAHAN; M LORR
Journal: J Consult Psychol Date: 1962-10

4. Further studies of the doctor as a crucial variable in the outcome of treatment with schizophrenic patients.

Authors: J C WHITEHORN; B J BETZ
Journal: Am J Psychiatry Date: 1960-09 Impact factor: 18.112

5. A contribution to the methodology of clinical appraisal of drug action.

Authors: E C KAST; J LOESCH
Journal: Psychosom Med Date: 1959 May-Jun Impact factor: 4.312

6. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo.

Authors: E H UHLENHUTH; A CANTER; J O NEUSTADT; H E PAYSON
Journal: Am J Psychiatry Date: 1959-04 Impact factor: 18.112

7. Why patients leave psychotherapy.

Authors: J D FRANK; L H GLIEDMAN; S D IMBER; E H NASH; A R STONE
Journal: AMA Arch Neurol Psychiatry Date: 1957-03

8. The personal element in psychiatric research.

Authors: P E FELDMAN
Journal: Am J Psychiatry Date: 1956-07 Impact factor: 18.112

9. Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy.

Authors: M B PARLOFF; H C KELMAN; J D FRANK
Journal: Am J Psychiatry Date: 1954-11 Impact factor: 18.112

10. Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses.

Authors: K Rickels; R S Lipman; S Fisher; L C Park; E H Uhlenhuth
Journal: Psychopharmacologia Date: 1970

17 in total

1. Therapeutic alliance in antidepressant treatment: cause or effect of symptomatic levels?

Authors: Sigal Zilcha-Mano; Steven P Roose; Jacques P Barber; Bret R Rutherford
Journal: Psychother Psychosom Date: 2015-03-28 Impact factor: 17.659

Review 2. Implications of placebo theory for clinical research and practice in pain management.

Authors: C Peck; G Coleman
Journal: Theor Med Date: 1991-09

3. Survey of investigators' opinions on the acceptability of interactions with patients participating in clinical trials.

Authors: Boadie W Dunlop; Christopher L Vaughan
Journal: J Clin Psychopharmacol Date: 2010-06 Impact factor: 3.153

Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.

1. PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.

2. AN ANALYSIS OF MOOD IN NEUROTICS.

3. Therapist "type" and patient response to psychotherapy.

4. Further studies of the doctor as a crucial variable in the outcome of treatment with schizophrenic patients.

5. A contribution to the methodology of clinical appraisal of drug action.

6. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo.

7. Why patients leave psychotherapy.

8. The personal element in psychiatric research.

9. Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy.

10. Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses.

1. Therapeutic alliance in antidepressant treatment: cause or effect of symptomatic levels?

Review 2. Implications of placebo theory for clinical research and practice in pain management.

3. Survey of investigators' opinions on the acceptability of interactions with patients participating in clinical trials.

4. The mental health clinic: a new model.

Review 5. Placebo effects: clinical aspects and neurobiology.

6. Reframing placebo in research and practice.

Review 7. Use of antianxiety agents in anxious outpatients.

8. Situational factors contributing to the placebos effect.

9. Predictive drug toxicity. Assessment of drug safety before human use.

10. Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome.